Aetna Inc (AET) 118.07 $AET Aetna (AET) Approaches New

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Aetna Inc (AET) 118.07 $AET

Aetna (AET) Approaches New Upside Target of $119.71
Comtex SmarTrend(R) - Wed Aug 05, 12:31PM CDT
Aetna (NYSE:AET) has opened bullishly above the pivot of $114.84 today and has reached the first level of resistance at $117.45. Analysts will be watching for a cross of the next upside pivot targets of $119.71 and $124.57.
AET: 118.07 (+2.88)

Relocating for Retirement? Here's What You Need to Know
at The Street - Wed Aug 05, 11:28AM CDT
Relocating for retirement involves a slew of costs, aside from just hiring movers.
ANTM: 154.95 (+2.45), CIG: 2.67 (-0.12), AET: 118.07 (+2.88), HUM: 185.54 (+3.21)

Health Net Tops Q2 Earnings on Memberships, Reaffirms View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 05, 10:40AM CDT
Health Net, Inc.'s (HNT) second-quarter 2015 operating income came in at 95 cents per share. The figure exceeded the Zacks Consensus Estimate of 88 cents.
CNC: 71.46 (+0.97), ANTM: 154.95 (+2.45), AET: 118.07 (+2.88), HNT: 69.03 (+0.38)

Company News for August 05, 2015 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Wed Aug 05, 9:10AM CDT
Companies in the News are: S,CVS,AET,CAR
S: 3.15 (-0.34), CAR: 43.84 (-1.24), CVS: 111.20 (+1.24), AET: 118.07 (+2.88)

DaVita Beats Q2 Earnings Estimates, Updates 2015 Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 05, 8:45AM CDT
DaVita HealthCare Partners Inc. (DVA) reported second-quarter 2015 adjusted operating earnings of 95 cents per share that surpassed the Zacks Consensus Estimate by 1.06%.
ANTM: 154.95 (+2.45), DVA: 80.49 (+0.29), AET: 118.07 (+2.88), MOH: 77.24 (+1.84)

Aetna achieves better net income of USD731.8m for second quarter of 2015
M2 - Wed Aug 05, 5:52AM CDT
Healthcare company Aetna (NYSE:AET) stated on Tuesday that it recorded a net income of USD731.8m for the second quarter of 2015.
AET: 118.07 (+2.88)

Business Highlights
By The Associated Press - AP - Tue Aug 04, 5:03PM CDT
___
BAX: 42.13 (+1.82), DIS: 110.53 (-11.16), CVS: 111.20 (+1.24), AET: 118.07 (+2.88), UAL: 58.11 (-0.84)

After Yesterday's Rally of 1.08% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Aug 04, 3:53PM CDT
Aetna (NYSE:AET) traded in a range yesterday that spanned from a low of $112.24 to a high of $117.10. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $114.98 on volume of 4.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AET: 118.07 (+2.88)

Watch for Aetna to Potentially Pullback After Gaining 1.08% Yesterday
Comtex SmarTrend(R) - Tue Aug 04, 3:53PM CDT
Aetna (NYSE:AET) traded in a range yesterday that spanned from a low of $112.24 to a high of $117.10. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $114.98 on volume of 4.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AET: 118.07 (+2.88)

Aetna (AET) Earnings Report: Q2 2015 Conference Call Transcript
at The Street - Tue Aug 04, 2:34PM CDT
The following Aetna (AET) conference call took place on August 4, 2015, 08:30 AM ET. This is a transcript of that earnings call:
AET: 118.07 (+2.88)

Stock Recover From Session Lows; Netflix Jumps
at The Street - Tue Aug 04, 2:01PM CDT
Stocks are slightly lower on Tuesday as Apple drags and Netflix jumps.
NFLX: 123.71 (+2.56), COH: 31.73 (+0.32), S: 3.15 (-0.34), CVS: 111.20 (+1.24), AIG: 62.96 (+0.62), TWTR: 28.48 (-0.86), AET: 118.07 (+2.88), AAPL: 115.40 (+0.76)


Aetna turns in better-than-expected 2Q, hikes forecast again
By TOM MURPHY - AP - Tue Aug 04, 12:07PM CDT
Aetna's second-quarter earnings jumped 33 percent and the health insurer raised its 2015 forecast again after receiving a boost from a government business it plans to feed with a roughly $35 billion acquisition.
CI: 147.55 (+3.66), CNC: 71.46 (+0.97), ANTM: 154.95 (+2.45), CTRX: 61.47 (+0.04), UNH: 123.92 (+3.08), ANTX: 51.10 (+0.37), CCT.TO: 80.18 (+0.12), AET: 118.07 (+2.88), HNT: 69.03 (+0.38), HUM: 185.54 (+3.21)

Aetna Beats on Q2 Earnings, Misses Revenue, Ups Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 04, 10:26AM CDT
Aetna (AET) earnings of $2.05 per share came in ahead of the Zacks Consensus Estimate of $1.84 per share.
CI: 147.55 (+3.66), UNH: 123.92 (+3.08), AET: 118.07 (+2.88), HUM: 185.54 (+3.21)

Stocks Fall as Apple Slumps, Netflix Hits All-Time High
at The Street - Tue Aug 04, 10:01AM CDT
Stocks are lower on Tuesday as Apple slips further into correction territory and Netflix hits an all-time high.
NFLX: 123.71 (+2.56), COH: 31.73 (+0.32), S: 3.15 (-0.34), CVS: 111.20 (+1.24), TM: 128.31 (-1.54), AIG: 62.96 (+0.62), TWTR: 28.48 (-0.86), AET: 118.07 (+2.88), AAPL: 115.40 (+0.76)

Aetna (AET) Stock Rises in Pre-Market Trading on Earnings Results
at The Street - Tue Aug 04, 8:21AM CDT
Aetna (AET) stock is increasing in pre-market trading as the company’s 2015 second quarter earnings per share results surpass estimates.
AET: 118.07 (+2.88)

Stock Futures Mixed; Apple in Correction Territory
at The Street - Tue Aug 04, 8:15AM CDT
Stock futures are mixed on Tuesday morning after a bumpy session a day earlier and as investors digest a rush of earnings from Coach to CVS Health.
COH: 31.73 (+0.32), S: 3.15 (-0.34), CVS: 111.20 (+1.24), TM: 128.31 (-1.54), AIG: 62.96 (+0.62), TWTR: 28.48 (-0.86), AET: 118.07 (+2.88), AAPL: 115.40 (+0.76)

Stocks Set For Lower Start; Regeneron Jumps On Earnings
at Investor's Business Daily - Tue Aug 04, 8:01AM CDT
Stock futures were on pace for a weak start Tuesday, despite a rebound in oil prices. Nasdaq 100 futures dropped 10 points vs. fair value, and S&P 500 futures lost 4 points. Futures on the Dow Jones industrial average slumped 28 points. The major...
ATVI: 28.71 (+3.04), FSLR: 51.92 (+7.42), BOOT: 27.39 (-5.76), CYH: 56.82 (-2.37), DIS: 110.53 (-11.16), ETSY: 13.78 (-5.45), CHUY: 34.22 (+6.39), EPAM: 70.14 (-2.85), AET: 118.07 (+2.88), CERN: 67.30 (-3.02), REGN: 592.40 (+11.46)

Aetna Q2 Earnings Beat Estimates, Guidance Raised - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Aug 04, 6:44AM CDT
Aetna Q2 Earnings Beat Estimates, Guidance Raised
AET: 118.07 (+2.88)

Aetna Reports Second-Quarter 2015 Results
Business Wire - Tue Aug 04, 5:00AM CDT
--Net income (2) per share was $2.08 for the second quarter of 2015
AET: 118.07 (+2.88)

Aetna, CVS, Disney, Sprint Earnings on Tap for Tuesday
at The Street - Mon Aug 03, 7:15PM CDT
Also, Papa John's and Charter earnings will be released along with important economic data.
ATVI: 28.71 (+3.04), COH: 31.73 (+0.32), S: 3.15 (-0.34), PZZA: 71.45 (-4.16), CHTR: 188.55 (-2.95), DIS: 110.53 (-11.16), CVS: 111.20 (+1.24), AET: 118.07 (+2.88)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 74

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 186

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 193

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 218

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 166

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 255

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 129

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 372

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 203

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 115

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading

Top 5 Most Recently Viewed Articles

BioSig Technologies Updates on Merger and Share Issuance Plans

Updated Category News Views 173

BioSig Technologies Provides Merger Update LOS ANGELES and VANCOUVER, British Columbia — BioSig Technologies, Inc. (NASDAQ: BSGM), recently provided a significant update regarding its merger with Streamex Exchange Corporation. The recent developments aim to clarify the status of the merger and ensure all shareholders are informed. Details of the Merger Finalization The...

Continue Reading
De La Rue plc: Key Information on Recent Trading Activities

Updated Category News Views 138

Overview of Recent Trading Activities De La Rue plc has recently made headlines through significant trading activities that reflect its status as a leading player in the security printing and cash management industry. As a key participant in financial and currency-related services, the company often finds itself at the crossroads of public interest and regulatory...

Continue Reading
Spar Nord's Strong Financial Performance in Q1 2025

Updated Category News Views 373

Spar Nord Reports Positive Q1 2025 Financial Results Profit after tax of DKK 491 million and return on equity of 14.0% Spar Nord has kicked off 2025 with a robust profit after tax of DKK 491 million, demonstrating a notable return on equity of 14.0%. While this performance marks a promising start for the year, it has been influenced by declining interest rates impacting...

Continue Reading
Latest Trends in CEO Confidence and Economic Outlook

Updated Category News Views 260

CEO Confidence Insights for Q4 2025 The Conference Board, in partnership with The Business Council, reported a slight decrease in the CEO Confidence measure, which now stands at 48 in the fourth quarter of 2025. This reflects a one-point drop from 49 during the third quarter. The readings below 50 indicate a dominantly negative sentiment among executives. In total, 130...

Continue Reading
Shift in Options Trading: Is Tesla Gaining Momentum Over Nvidia?

Updated Category News Views 301

Shift in Options Trading Dynamics The S&P 500 experienced a modest increase, climbing by around 20 basis points, while the NASDAQ 100 saw a more substantial rise, soaring by an impressive 80 basis points. A significant contributor to this market movement was none other than Tesla (NASDAQ: TSLA), which experienced a remarkable surge of about 20% in its stock price....

Continue Reading